Your browser doesn't support javascript.
loading
Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation.
Smirnikhina, Svetlana A; Chelysheva, Ekaterina Yu; Lavrov, Alexander V; Kochergin-Nikitsky, Konstantin S; Mozgovoy, Ivan V; Adilgereeva, Elmira P; Shukhov, Oleg A; Petrova, Anna N; Bykova, Anastasia V; Abdullaev, Adhamjon O; Turkina, Anna G; Kutsev, Sergey I.
Afiliación
  • Smirnikhina SA; a Laboratory of Mutagenesis , FSBI "Research Centre for Medical Genetics" , Moscow , Russian Federation.
  • Chelysheva EY; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI "National Research Center for Hematology" of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation.
  • Lavrov AV; a Laboratory of Mutagenesis , FSBI "Research Centre for Medical Genetics" , Moscow , Russian Federation.
  • Kochergin-Nikitsky KS; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation.
  • Mozgovoy IV; a Laboratory of Mutagenesis , FSBI "Research Centre for Medical Genetics" , Moscow , Russian Federation.
  • Adilgereeva EP; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation.
  • Shukhov OA; a Laboratory of Mutagenesis , FSBI "Research Centre for Medical Genetics" , Moscow , Russian Federation.
  • Petrova AN; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI "National Research Center for Hematology" of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation.
  • Bykova AV; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI "National Research Center for Hematology" of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation.
  • Abdullaev AO; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI "National Research Center for Hematology" of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation.
  • Turkina AG; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI "National Research Center for Hematology" of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation.
  • Kutsev SI; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI "National Research Center for Hematology" of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation.
Leuk Lymphoma ; 59(10): 2512-2515, 2018 10.
Article en En | MEDLINE | ID: mdl-29424604
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Biomarcadores de Tumor / Inhibidores de Proteínas Quinasas / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Biomarcadores de Tumor / Inhibidores de Proteínas Quinasas / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article